Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shouwen Zhang, Jingfang Li, Shunpeng Hu, Fangfang Wu & Xianzhao Zhang. (2018) Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. International Journal of Nanomedicine 13, pages 4045-4057.
Read now
Read now
Articles from other publishers (21)
Javed Iqbal, Ather Iqbal, Hammad Mukhtar, Kainat Jahangir, Yusra Mashkoor, Muhammad Hamayl Zeeshan, Abdullah Nadeem, Ahmer Ashraf, Shahzaib Maqbool, Sauban Mansoor Sadiq & Ka Yiu Lee. (2023) Cardioprotective Effects of Nanoparticles in Cardiovascular Diseases: A State-of-the-Art Review. Current Problems in Cardiology 48:8, pages 101713.
Crossref
Crossref
Bryan Ronain Smith & Elazer R. Edelman. (2023) Nanomedicines for cardiovascular disease. Nature Cardiovascular Research 2:4, pages 351-367.
Crossref
Crossref
Demin Li, Kang Tian, Jiacheng Guo, Qiguang Wang, Zhen Qin, Yongzheng Lu, Yanyan Xu, Nicola Scott, Chris J Charles, Guozhen Liu, Jinying Zhang, Xiaolin Cui & Junnan Tang. (2022) Growth factors: avenues for the treatment of myocardial infarction and potential delivery strategies. Regenerative Medicine 17:8, pages 561-579.
Crossref
Crossref
Pooja Jain, Thomson Santosh Alex, Manvi Singh, Nazia Hassan, Mohd. Aamir Mirza & Zeenat Iqbal. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders
31
45
.
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2022. Nanocarriers for Organ-Specific and Localized Drug Delivery. Nanocarriers for Organ-Specific and Localized Drug Delivery
77
101
.
Xiao-Min Luo, Cen Yan & Ying-Mei Feng. (2021) Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis. Advanced Drug Delivery Reviews 172, pages 234-248.
Crossref
Crossref
Xuwei Zhu, Xinli Hu, Junsheng Lou, Jiafeng Li, Yu Xu, Gaoxiang Yu, Chenyu Wu, Jian Ding, Weiyang Gao, Jian Xiao, Kailiang Zhou & Chang Jia. (2021) Liraglutide, a TFEB-Mediated Autophagy Agonist, Promotes the Viability of Random-Pattern Skin Flaps. Oxidative Medicine and Cellular Longevity 2021, pages 1-18.
Crossref
Crossref
Joëlle Bizeau & Damien Mertz. (2021) Design and applications of protein delivery systems in nanomedicine and tissue engineering. Advances in Colloid and Interface Science 287, pages 102334.
Crossref
Crossref
Xiaotong Yang, Xiaoying Ma, Ocholi Don, Yuanlin Song, Xiaoyan Chen, Jianwen Liu, Jieming Qu & Yun Feng. (2020) Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin. Stem Cell Research & Therapy 11:1.
Crossref
Crossref
Quan Qi, Yanlun Zhu, Gang Liu, Zhize Yuan, Haiyan Li & Qiang Zhao. (2020) Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration. Biomedicine & Pharmacotherapy 129, pages 110382.
Crossref
Crossref
Saltanat Smagul, Yevgeniy Kim, Aiganym Smagulova, Kamila Raziyeva, Ayan Nurkesh & Arman Saparov. (2020) Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. International Journal of Molecular Sciences 21:17, pages 5952.
Crossref
Crossref
Mauro Cataldi, Angelo Cignarelli, Francesco Giallauria, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano & Annamaria Colao. (2020) Cardiovascular effects of antiobesity drugs: are the new medicines all the same?. International Journal of Obesity Supplements 10:1, pages 14-26.
Crossref
Crossref
Chengming Fan, Jyotsna Joshi, Fan Li, Bing Xu, Mahmood Khan, Jinfu Yang & Wuqiang Zhu. (2020) Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Morteza Aieneravaie, Jim Q. Ho, Leila Arabi, James Lee, Kirsten Herrera, Syeda Mehreen, Najmeh Javdani, Petrina Georgala, Mohammad Reza Sepand, Marjan Rafat & Steven Zanganeh. 2020. Nanomedicine for Ischemic Cardiomyopathy. Nanomedicine for Ischemic Cardiomyopathy
89
111
.
Chong Liu, Yong Liu, Jing He, Rong Mu, Yanbo Di, Na Shen, Xuan Liu, Xiao Gao, Jinhui Wang, Tie Chen, Tao Fang, Huanming Li & Fengshi Tian. (2019) Liraglutide Increases VEGF Expression via CNPY2-PERK Pathway Induced by Hypoxia/Reoxygenation Injury. Frontiers in Pharmacology 10.
Crossref
Crossref
Ying Cheng, Dao-zhou Liu, Chang-xiong Zhang, Han Cui, Miao Liu, Bang-le Zhang, Qi-bing Mei, Zi-fan Lu & Si-yuan Zhou. (2019) Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injury through a multistage continuous targeted strategy. Nanomedicine: Nanotechnology, Biology and Medicine 16, pages 236-249.
Crossref
Crossref
Aswathi Gopalakrishnan, Sahadev A. Shankarappa & G. K. Rajanikant. (2018) Hydrogel Scaffolds: Towards Restitution of Ischemic Stroke-Injured Brain. Translational Stroke Research 10:1, pages 1-18.
Crossref
Crossref
Qian Huang, Chan Liu, Jia‑Rui Li, Ling Zhang, Fu‑Chang Huang, Dan Wang & Ya‑Jing Luo. (2019) Incremental effect of liraglutide on traditional insulin injections in rats with type 2 diabetes mellitus by maintaining glycolipid metabolism and cardiovascular function. Experimental and Therapeutic Medicine.
Crossref
Crossref
Laura Saludas, Simón Pascual-Gil, Filippo Roli, Elisa Garbayo & María J. Blanco-Prieto. (2018) Heart tissue repair and cardioprotection using drug delivery systems. Maturitas 110, pages 1-9.
Crossref
Crossref
Adegbenro Omotuyi John Fakoya, David Adeiza Otohinoyi & Joshua Yusuf. (2018) Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration. Stem Cells International 2018, pages 1-32.
Crossref
Crossref
Hoda M. Eltaher, Somiraa S. Said & Labiba K. El-Khordagui. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery
283
321
.